Other cations and co-administered medications

Other cations and co-administered medications is a pharmacological category rather than a specific biological target like a receptor or enzyme. This term is frequently used in clinical literature and drug labeling to describe substances that interfere with the absorption, distribution, metabolism, or excretion of a primary drug (StatPearls, 2023). The cations typically include multivalent metal ions such as calcium, magnesium, aluminum, iron, and zinc, which are prevalent in antacids, mineral supplements, and dairy products (FDA, 2020). These ions can form insoluble chelates with drugs like fluoroquinolones and tetracyclines, preventing their absorption in the gastrointestinal tract (PubMed, 2021). Co-administered medications refers to the broader context of drug-drug interactions, where one agent may inhibit or induce metabolic enzymes like Cytochrome P450 or affect transport proteins like P-glycoprotein (NIH, 2022). Managing these interactions is vital for maintaining therapeutic efficacy and preventing adverse drug reactions or toxicity (EMA, 2012).

Other names

Multivalent cationsPolyvalent metal ionsDrug-drug interactionsDrug-nutrient interactionsChelating agents

The primary mechanisms include physical chelation or complexation with multivalent cations (e.g., Ca2+, Mg2+, Al3+, Fe2+/3+, Zn2+), which forms insoluble compounds that cannot be absorbed by the gastrointestinal tract (StatPearls, 2023). Additionally, co-administered medications may interact via the inhibition or induction of Cytochrome P450 (CYP) enzymes, competition for renal tubular secretion, or modulation of drug transporters such as P-glycoprotein (NIH, 2022).